OxySure (OXYS) Signs Exclusive Contract in Singapore

Report this content

Frisco, Texas, December 4, 2014 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced that the Company has signed an exclusive distribution agreement with HTM Medico Pte Ltd in Singapore. The agreement appoints HTM Medico as the Company’s exclusive distributor in Singapore, and requires an annual minimum purchase commitment of 1,250 units of Model 615, valuing the contract at $1.3 million in the first 5 years.

HTM Medico is a leading distributor of Automated External Defibrillators (AEDs) and Electrocardiogram (ECG) equipment in Singapore, focused on commercial and government markets.

“We are pleased to add Singapore to our rapidly growing global footprint,” said Julian T. Ross, CEO of OxySure. “We look forward to working with HTM Medico on the immediate next step of getting approval from the Singapore Health Sciences Authority and to develop the Singapore market.”

About OxySure Systems, Inc.

OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com

About HTM Medico

HTM’s a leading major supplier of good quality and affordable Portable / Home Medical Devices and Cardiac Related Equipment. HTM is focused educating people on how to take charge of their own health and embrace a healthier life. http://www.htmmedico.com.sg/

Forward-Looking Statements

Statements in this earnings release that are not historical facts are considered to be forward-looking statements. Such statements include, but are not limited to, statements regarding management beliefs and expectations, based upon information available at the time the statements are made, regarding future plans, objectives and performance. All forward-looking statements are subject to risks and uncertainties, many of which are beyond management’s control and actual results and performance may differ significantly from those contained in forward-looking statements. OxySure Systems, Inc. intends any forward-looking statement to be covered by the Litigation Reform Act of 1995 and is including this statement for purposes of said safe harbor provisions. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release. OxySure Systems, Inc. undertakes no obligation to update any forward-looking statements to reflect events or circumstances that occur after the date as of which such statements are made. A discussion of certain risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements is included in OxySure Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2013.

Investor Contacts:

Stonegate Securities, Inc.

214-987-4121 / 972-294-6461

investors@oxysure.com

http://www.stonegateinc.com/

Renmark Financial Communications, Inc.

Bettina Filippone: bfilippone@renmarkfinancial.com

John Boidman: jboidman@renmarkfinancial.com

Tel.: (416) 644-2020 or (514) 939-3989

www.renmarkfinancial.com/

Tags: